Atlanta vaccine developer takes hit

Add this share

Atlanta-based HIV/AIDS vaccine developer GeoVax Labs posted a loss of $1.28 million and break-even earnings for the second quarter of 2008. The company says the loss was partially offset by grant revenue from the National Institutes of Health in support of its HIV/AIDS vaccine work.

The company still expects to launch a Phase 2 preventative AIDS vaccine clinical trial this fall.

THE LATEST

Project Q Atlanta goes on hiatus after 14 years

On Sept. 1, 2008, Project Q Atlanta promised a hyper-local “queer media diet” for Atlanta. The site set out to bring LGBTQ news, in-depth...

Photos catch Purple Dress Run invading Midtown

After three years of pandemic-inflicted limitations, Atlanta’s gay rugby squad let loose on one of its most popular events. The Atlanta Bucks Purple Dress...

Ooo Bearracuda: Photos from Bear Pride’s Main Event

The seventh annual Atlanta Bear Pride hit the ground running on Friday with packed houses at Woofs, Heretic and Future. Turned out, they hadn’t...

Atlanta Bear Pride set to go hard and long all weekend

That low, growing growl you hear is a nation of gay bears headed for Atlanta Bear Pride this weekend. By the time they arrive,...

PHOTOS: Armorettes bring back Easter Drag Race magic

Gay Atlanta’s queens of do-good drag brought the sunshine to a cloudy afternoon on Saturday when Heretic hosted the triumphant return of Armorettes Easter...
17,446FansLike
7,001FollowersFollow
7,682FollowersFollow

PHOTO GALLERIES